Status:
COMPLETED
Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis C, Chronic
Hepacivirus
Eligibility:
All Genders
18+ years
Brief Summary
Several psychiatric adverse events (eg, depression, fatigue, psychoses, behavior troubles, anxiety, irritability, deteriorated concentration, and insomnia) that are likely to occur during the treatmen...
Detailed Description
Enrollment of participants will occur in a sequential order of treatment initiation.
Eligibility Criteria
Inclusion
- Adult patients with hepatitis C
Exclusion
- According to the products' labeling
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
614 Patients enrolled
Trial Details
Trial ID
NCT00723892
Start Date
July 1 2005
End Date
May 1 2009
Last Update
October 30 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.